Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The HMGA2 mRNA 3'-untranslated region (3'-UTR) is a critical regulatory segment of the High Mobility Group AT-Hook 2 transcript, spanning approximately 3 kilobases and containing multiple evolutionary conserved binding sites for the let-7 microRNA family. Under normal physiological conditions, let-7 binds to this region to suppress HMGA2 expression, thereby regulating cell proliferation and differentiation. In many cancers, chromosomal translocations or deletions lead to the loss of the 3'-UTR, resulting in 'let-7-mediated escape' and subsequent overexpression of the HMGA2 protein, which drives oncogenic processes such as the epithelial-mesenchymal transition (EMT) and metastasis. As a therapeutic target, the HMGA2 mRNA 3'-UTR is being explored for the development of RNA-targeted therapies, including antisense oligonucleotides and small molecules designed to either mimic microRNA suppression or prevent the oncogenic stabilization of the transcript. Targeting this region offers a strategy to downregulate a potent driver of tumor progression that is otherwise difficult to inhibit at the protein level.
Modulation of mRNA stability and translation efficiency through the competitive inhibition or enhancement of microRNA binding (specifically the let-7 family) or through antisense-mediated degradation of the transcript.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on High mobility group AT-hook 2 mRNA 3'-untranslated region (HMGA2 mRNA 3'-UTR).